Navigation Links
DFG announces recipients of 2013 Heinz Maier-Leibnitz Prize
Date:5/7/2013

This news release is available in German.

This year's recipients of the most important prize for early career researchers in Germany have been announced. The selection committee appointed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the German Federal Ministry of Education and Research (BMBF) have chosen nine researchers, four women and five men, to receive the 2013 Heinz Maier-Leibnitz Prize. This year the BMBF has increased the prize money from 16,000 to 20,000 per prize. The number of recipients also increased, with only six prizes having been awarded in previous years. The awards ceremony for the 2013 Heinz Maier-Leibnitz Prizes will be held on 3 June in Berlin.

The higher number of awards and the increased prize money reflect the excellent reputation of the prize, which has been awarded annually since 1977. In a survey carried out by bild der wissenschaft magazine, the Heinz Maier-Leibnitz Prize was voted the third most important research prize in Germany by the leading research institutions after the Gottfried Wilhelm Leibniz Prize, presented by the DFG, and the Deutscher Zukunftspreis, awarded by the German Federal President. The DFG sees the Heinz Maier-Leibnitz Prize as both recognition and an incentive to early career researchers to continue pursuing a path in research.

This year's recipients are:

  • Christine Hentschel, Sociology, Humboldt University of Berlin

  • Lena Maier-Hein, Medical Informatics, German Cancer Research Centre, Heidelberg

  • Nuno Maulide, Organic Chemistry, Max-Planck-Institut fr Kohlenforschung, Mlheim

  • Nicole Megow, Discrete Mathematics/Computer Science, Technical University of Berlin

  • Thomas Pfeifer, Physics, Max Planck Institute for Nuclear Physics, Heidelberg

  • Holger Johannes Pletsch, Astrophysi
    '/>"/>

Contact: Cornelia Lossau
cornelia.lossau@dfg.de
49-302-061-214-328
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. PLOS announces Accelerating Science Award Program
2. AAPS announces 2013 National Biotechnology Conference award winners
3. Merck Animal Health announces Vetsulin
4. Keystone Symposia announces grant from Alfred P. Sloan Foundation
5. Energy Department announces 5-year renewal of funding for Bioenergy Research Centers
6. Research and Markets Announces the Release of Multi-Factor Authentication Market - by Model/Type [Two, Three, Four & Five-Factor], Application & Geography - Forecasts (2012 - 2017)
7. Brain & Behavior Research Foundation announces spring 2013 conference & free webinars
8. Frontiers announces launch of new open-access journal, Frontiers in Public Health
9. Elsevier announces the launch of a new journal: Wound Medicine
10. Pew announces 2013 Marine Fellows
11. St. Jude Childrens Research Hospital announces issuance of US patent for cancer therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... and TELTOW, Germany , August ... (SMI), a world leader in Eye Tracking Technology ... of its OEM Eye Tracking Platform for integration into ... Platform contains reference designs for seamless integration of eye ... virtual reality HMDs and augmented reality smart glasses. Omnivision,s ...
(Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... past several decades have led to heritable, genetic changes ... according to University of Oregon evolutionary geneticists. , Writing ... of SCIENCE, William E. Bradshaw, professor of biology, and ... populations have changed genetically in response to rapid climate ...
... years, scientists have identified a new genus of a living ... Science May 11 in the online Science Express. , ... of discovery' is by no means over," says William Stanley, ... The Field Museum, where the world's only specimen of this ...
... Kavli Institute of Nanoscience have discovered how to use ... on a chip. Based on this, they built a ... molecules individually. To demonstrate this, the Delft researchers sorted ... of the University of Florida has called the Delft ...
Cached Biology News:Recent, rapid climate change is driving evolution of animal species 2Scientists describe new African monkey genus ?first in 83 years 2Scientists describe new African monkey genus ?first in 83 years 3Biological motors sort molecules one by one on a chip 2
(Date:8/27/2015)... 2015 HUYA Bioscience International (HUYA) today announced the ... Society of HTLV-1, held this week at the University ... the Society is to promote research on HTLV-1 and ... technology and research related to these fields to advance ... is proud to support this prestigious conference," said ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, ... on the relationship of genetics and hypertension at the International Academy of ... Vancouver, British Columbia, Canada. The event, which boasts an extensive overview of the ...
(Date:8/26/2015)... 26, 2015  The Diabetes Research Institute (DRI), ... Miami Miller School of Medicine, announced today that ... test for the first time a novel transplant ... FDA approved Phase I/II study builds upon decades ... an important first step toward the development of ...
(Date:8/26/2015)... 26, 2015 After litigating and negotiating ... relating to P2i United States patent ... in the United States without any ... of either party. As a result of the parties, settlement, ... California dismissed the case without prejudice. ...
Breaking Biology Technology:HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4P2i Settles United States Litigation 2
... ROUGE, La., Sept. 10 Drug discovery and development ... enrollment and dosing of patients in a Phase 1 ... EP-100, the lead candidate from Esperance,s Cationic Lytic Peptide ... designed to seek and destroy cancer cells that over-express ...
... TAI,AN, Shandong, China, Sept. ... Bulletin Board: CBPO) ("China Biologic," or the,"Company"), ... in the,People,s Republic of China ("PRC"), operating ... Products Co. Ltd.,("Taibang") and Chongqing Dalin Biologic ...
... CORK, Ireland, September 10 Hovione announced today that,Terry Lambe, Ph.D., ... , Hovione acquired earlier this year an ... of the Hovione strategy to become a,leading manufacturer to the pharmaceutical ... Terry Lambe to Hovione. We want to build our,Cork site into ...
Cached Biology Technology:Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer 2Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer 3China Biologic Products to Attend at Susquehanna's Third Annual Beijing Management Summit 2China Biologic Products to Attend at Susquehanna's Third Annual Beijing Management Summit 3Hovione Appoints Terry Lambe to its Board of Directors 2